NK:IO raises £1.2 million to advance 'pioneering' NK cell therapy

NK:IO, a leader in natural killer (NK) cell biology applied to the development of potent, off-the-shelf cell therapies targeting solid tumors, has raised £1.2m.

Related Keywords

United Kingdom ,Hugh Brady ,Matt Fuchter ,Tony Hickson ,Imperial College Enterprise Fund ,Imperial College ,Cancer Research Horizons ,Cancer Research United Kingdom ,United Kingdom Innovation Science Seed Fund ,Innovate United Kingdom New Cancer Therapeutics ,Innovate United Kingdom Accelerator ,Start Codon ,United Kingdom Innovation ,Science Seed Fund ,Gene Therapy Catapult ,Innovate United Kingdom ,New Cancer Therapeutic ,Research Horizons ,Markets Amp Regulations ,Pipelines ,Emerging Markets ,Cell Amp Gene Therapies ,Cell Therapy ,Humor ,Cell And Gene Therapy ,Cancer Research ,Dancer ,